Literature DB >> 6814551

Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo.

N Kamatani, A L Yu, D A Carson.   

Abstract

Cells from 20 patients with leukemia and 9 with solid tumors were assayed for the enzyme methylthioadenosine phosphorylase, which function in both purine and polyamine metabolism in rapidly dividing cells. As determined by autoradiography of viable cells, and by direct enzymatic analysis, samples from one individual with pre-T-cell acute lymphoblastic leukemia and one with common acute lymphoblastic leukemia were methylthioadenosine phosphorylase deficient. In contrast, other leukemias of similar antigenic phenotype, as well as normal peripheral blood lymphocytes, thymic lymphocytes, and normal bone marrow cells, had substantial methylthioadenosine phosphorylase activity. This evidence suggests that the complete absence of methylthioadenosine phosphorylase distinguishes some leukemic cells in vivo from their nonmalignant counterparts.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814551

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Six-layer structure for genomics and its applications.

Authors:  Naoyuki Kamatani
Journal:  J Hum Genet       Date:  2015-11-12       Impact factor: 3.172

2.  A polymorphic region defined by pCN2 (the 3' nontranslated region of N-ras) maps to chromosome 9cen-p12.

Authors:  T Nobori; L E Hexdall; D A Carson
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

Review 3.  Sulphane sulphur in biological systems: a possible regulatory role.

Authors:  J I Toohey
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

4.  Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts.

Authors:  Olga Camacho-Vanegas; Sandra Catalina Camacho; Jacob Till; Irene Miranda-Lorenzo; Esteban Terzo; Maria Celeste Ramirez; Vern Schramm; Grace Cordovano; Giles Watts; Sarju Mehta; Virginia Kimonis; Benjamin Hoch; Keith D Philibert; Carsten A Raabe; David F Bishop; Marc J Glucksman; John A Martignetti
Journal:  Am J Hum Genet       Date:  2012-03-29       Impact factor: 11.025

5.  Methylthioadenosine phosphorylase in human breast cancer.

Authors:  R Smaaland; J S Schanche; S Kvinnsland; J Høstmark; P M Ueland
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

6.  EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.

Authors:  Ayse Batova; Howard Cottam; John Yu; Mitchell B Diccianni; Carlos J Carrera; Alice L Yu
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

7.  Lupus autoimmunity altered by cellular methylation metabolism.

Authors:  Mei-Ling Yang; Alaric J P Gee; Renelle J Gee; Cecilia I Zurita-Lopez; Shilpi Khare; Steven G Clarke; Mark J Mamula
Journal:  Autoimmunity       Date:  2012-11-01       Impact factor: 2.815

8.  Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridization.

Authors:  C J Carrera; R L Eddy; T B Shows; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.

Authors:  M O Diaz; S Ziemin; M M Le Beau; P Pitha; S D Smith; R R Chilcote; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Deficiency of 5'-deoxy-5'-methylthioadenosine phosphorylase activity in malignancy. Absence of the protein in human enzyme-deficient cell lines.

Authors:  F Della Ragione; A Oliva; R Palumbo; G L Russo; V Gragnaniello; V Zappia
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.